Preparing samples for mass spectrometry analysis, Vaccines, Toronto Campus, Canada
Preparing samples for mass spectrometry analysis, Vaccines, Toronto Campus, Canada
Second Quarter 2026 Results
The results were reviewed by management during a live audio webcast with the financial community on July 30, 2026.
Learn moreOur Latest Articles
Our Science
July 28, 2026
One Target, One Answer. Two Targets, a Thousand Questions.
The Power of Chasing A Dream
Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you
People Stories
We’re proud to spotlight those who inspire us to keep going further in the work we do.
Céline, living with secondary progressive multiple sclerosis
France
We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth.
About Us
Who We Are
We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.
Our Pipeline
5
Therapeutic areas
61
Compounds in clinical development
20
Clinical trials in phase 3
Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.